|1.||Liu, Zhihao: 1 article (02/2015)|
|2.||Li, Yan: 1 article (02/2015)|
|3.||Sheng, Li: 1 article (02/2015)|
|4.||Zhao, Manman: 1 article (02/2015)|
|5.||Liu, Xin: 1 article (02/2015)|
|6.||Mi, Jiaqi: 1 article (02/2015)|
|7.||Mancini, Ines: 1 article (01/2015)|
|8.||Balzarini, Jan: 1 article (01/2015)|
|9.||Defant, Andrea: 1 article (01/2015)|
|10.||Tomazzolli, Rossella: 1 article (01/2015)|
|2.||HIV Infections (HIV Infection)
02/01/2015 - "F18 (10-chloromethyl-11-demethyl-12-oxo-calanolide), an analog of (+)-Calanolide A, is a novel small-molecule nonnucleoside reverse transcriptase inhibitor for the therapy of human immunodeﬁciency virus (HIV) infection. "
01/01/2015 - "In search for more effective drugs against HIV infection acting as non-nucleoside reverse transcriptase inhibitors (NNRTIs), a series of new molecules with hybrid structures based on the natural product (+)-calanolide A and the synthetic molecule α-APA, known as potent and selective inhibitors of this enzyme, were selected by docking calculations. "
09/01/1998 - "Both (+)-calanolide A (Cal A; NSC 675451) and (+)-dihydrocalanolide A (DHCal A; NSC 678323) are currently under development for the treatment of HIV infections. "
|3.||Acquired Immunodeficiency Syndrome (AIDS)
10/01/1998 - "(+)-Calanolide A, a novel dipyranocoumarin from the Malesian tree Calophyllum lanigerum var. austrocoriaceum, and a closely related compound, (-)-calanolide B, isolated from Calophyllum teysmannii var. inophylloide, are representatives of a distinct class of nonnucleoside HIV-1 specific reverse-transcriptase inhibitor under development as an AIDS chemotherapeutic. "
|1.||HIV Reverse Transcriptase
|2.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|3.||Reverse Transcriptase Inhibitors